CIK: 1740858
GALILEO (PTC) LTD
Address: c/o Goodwin Procter LLP, 1900 N Street, N.W., Washington, DC 20036
α Alpha 0.9100↭ Flow 0.1700Pure Active
4holdings (Q4 2025)
$1.37B13F reported value
+3 INCREASED-1 DECREASED
Total (Q4 25): $1,372,708,819
Top Holdings by Value
Top 15 Positions ($)
Historical AUM (13F Reported)
$1.69B-$1.69B QoQPortfolio Value History (13F Reported)
Quarterly 13F portfolio value. QoQ change reflects value of disclosed long equity positions (new buys, sells, and price movements combined).
| Quarter | Portfolio Value | QoQ Change | QoQ % |
|---|---|---|---|
| Q4 25 | $1.37B | +$0.26B | +23.7% |
| Q3 25 | $1.11B | $-0.75B | -40.3% |
| Q2 25 | $1.86B | +$1.79B | +2,745.9% |
| Q1 25 | $0.07B | +$0.01B | +15.1% |
| Q4 24 | $0.06B | $-0.79B | -93.3% |
| Q3 24 | $0.85B | $-0.48B | -36.3% |
| Q2 24 | $1.33B | $-0.36B | -21.4% |
| Q1 24 | $1.69B | $-0.63B | -27.2% |
| Q4 23 | $2.33B | $-0.96B | -29.3% |
| Q3 23 | $3.29B | $-0.96B | -22.7% |
| Q2 23 | $4.25B | +$0.88B | +25.9% |
| Q1 23 | $3.38B | — | — |
QoQ = (quarter 13F value − prior quarter value) ÷ prior quarter value. Includes position changes, new buys, and exits. Not investment advice.
Information for Viewing 13F Reports:
- Name: The name of the company.
- CUSIP: A unique 9-character alphanumeric code that identifies a specific stock or security in the U.S.
- Class: The investment company's series name. A registered investment company may have multiple series, each with a separate securities portfolio.
- Value: The monetary value of the holdings in USD.
- Shares: The number of shares held.
- Share Price: The price of shares at the time of filing.
- Investment: The type of investment.
- % of Portfolio: The percentage that this position represents in the total portfolio.
| Quarter | Period of Report | Holdings | Value | Type | Filling Date | Filling ID |
|---|---|---|---|---|---|---|
| Q4 25 | 31-Dec-2025 | 4 | $1,372,708,819 | 13F-HR | 17-Feb-2026 | 0001193125-26-053948 |
| Q3 25 | 30-Sep-2025 | 4 | $1,109,750,900 | 13F-HR | 12-Nov-2025 | 0001193125-25-277922 |
| Q2 25 | 30-Jun-2025 | 3 | $1,859,793,990 | 13F-HR | 14-Aug-2025 | 0000950123-25-008253 |
| Q1 25 | 31-Mar-2025 | 2 | $65,349,702 | 13F-HR | 13-May-2025 | 0000950123-25-004950 |
| Q4 24 | 31-Dec-2024 | 2 | $56,770,149 | 13F-HR | 14-Feb-2025 | 0000950123-25-002617 |
| Q3 24 | 30-Sep-2024 | 6 | $847,747,237 | 13F-HR | 8-Nov-2024 | 0000950123-24-010642 |
| Q2 24 | 30-Jun-2024 | 7 | $1,330,312,575 | 13F-HR | 13-Aug-2024 | 0000950123-24-008104 |
| Q1 24 | 31-Mar-2024 | 7 | $1,692,716,098 | 13F-HR | 14-May-2024 | 0000950123-24-005104 |
| Q4 23 | 31-Dec-2023 | 8 | $2,326,264,903 | 13F-HR | 14-Feb-2024 | 0000950123-24-002082 |
| Q3 23 | 30-Sep-2023 | 8 | $3,289,630,837 | 13F-HR | 14-Nov-2023 | 0000950123-23-010395 |
| Q2 23 | 30-Jun-2023 | 7 | $4,254,134,805 | 13F-HR | 14-Aug-2023 | 0000950123-23-007812 |
| Q1 23 | 31-Mar-2023 | 7 | $3,378,628,304 | 13F-HR | 15-May-2023 | 0000950123-23-005057 |
| Q4 22 | 31-Dec-2022 | 7 | $2,827,363,205 | 13F-HR | 14-Feb-2023 | 0000950123-23-002246 |
| Q3 22 | 30-Sep-2022 | 7 | $3,062,682,000 | 13F-HR | 14-Nov-2022 | 0000950123-22-011943 |
| Q2 22 | 30-Jun-2022 | 7 | $2,899,336,000 | 13F-HR | 12-Aug-2022 | 0000950123-22-008885 |
| Q1 22 | 31-Mar-2022 | 8 | $5,559,678,000 | 13F-HR | 16-May-2022 | 0000950123-22-006029 |
| Q1 22 | 31-Mar-2022 | 8 | $5,559,678,000 | 13F-HR/A | 12-Aug-2022 | 0000950123-22-008888 |
| Q4 21 | 31-Dec-2021 | 7 | $7,185,129,000 | 13F-HR/A | 12-Aug-2022 | 0000950123-22-008883 |
| Q4 21 | 31-Dec-2021 | 7 | $7,185,129,000 | 13F-HR | 14-Feb-2022 | 0000950123-22-002922 |
| Q3 21 | 30-Sep-2021 | 7 | $6,159,839,000 | 13F-HR | 15-Nov-2021 | 0000950123-21-015330 |
| Q2 21 | 30-Jun-2021 | 8 | $4,150,561,000 | 13F-HR | 16-Aug-2021 | 0000950123-21-011386 |
| Q1 21 | 31-Mar-2021 | 6 | $4,192,539,000 | 13F-HR | 17-May-2021 | 0000950123-21-006856 |
| Q4 20 | 31-Dec-2020 | 6 | $4,759,050,000 | 13F-HR | 16-Feb-2021 | 0000950123-21-002709 |
| Q3 20 | 30-Sep-2020 | 4 | $887,808,000 | 13F-HR | 16-Nov-2020 | 0000950123-20-011969 |
| Q2 20 | 30-Jun-2020 | 4 | $656,214,000 | 13F-HR | 14-Aug-2020 | 0000950123-20-008852 |
| Q1 20 | 31-Mar-2020 | 2 | $73,523,000 | 13F-HR | 15-May-2020 | 0000950123-20-005141 |
| Q4 19 | 31-Dec-2019 | 2 | $110,624,000 | 13F-HR | 14-Feb-2020 | 0000950123-20-002576 |
| Q3 19 | 30-Sep-2019 | 2 | $90,182,000 | 13F-HR | 14-Nov-2019 | 0000950123-19-011156 |
| Q2 19 | 30-Jun-2019 | 2 | $201,774,000 | 13F-HR | 14-Aug-2019 | 0000950123-19-008155 |
| Q1 19 | 31-Mar-2019 | 2 | $250,179,000 | 13F-HR | 15-May-2019 | 0000950123-19-005201 |
| Q4 18 | 31-Dec-2018 | 2 | $257,067,000 | 13F-HR | 14-Feb-2019 | 0000950123-19-002005 |
| Q3 18 | 30-Sep-2018 | 3 | $407,492,000 | 13F-HR | 14-Nov-2018 | 0000950123-18-011821 |
| Q2 18 | 30-Jun-2018 | 1 | $215,000 | 13F-HR | 14-Aug-2018 | 0000950123-18-008623 |
| Q1 18 | 31-Mar-2018 | 1 | $207,000 | 13F-HR | 16-May-2018 | 0000950123-18-005833 |